Ryabov V V, Krylov A L, Poponina Yu S, Maslov L N
Institute of Cardiology, Tomsk Research Center, Siberian Division of Russian Academy of Medical Sciences.
Bull Exp Biol Med. 2006 Jan;141(1):124-8. doi: 10.1007/s10517-006-0111-6.
Autologous bone marrow mononuclear cells were transplanted by intracoronary infusion to patients with myocardial infarction after recovery of coronary perfusion. Controls received traditional therapy alone. Echocardiography was carried out before and 3 and 6 months after cell therapy. Cell transplantation did not appreciably improved left-ventricular contractility in comparison with the control group. In none patient cell therapy provoked malignant ventricular arrhythmias. Intracoronary infusion of bone marrow mononuclear cells in patients with myocardial infarction did not improve cardiac contractility and did not aggravate the course of the disease.
在冠状动脉灌注恢复后,通过冠状动脉内输注将自体骨髓单个核细胞移植到心肌梗死患者体内。对照组仅接受传统治疗。在细胞治疗前以及治疗后3个月和6个月进行超声心动图检查。与对照组相比,细胞移植并未明显改善左心室收缩功能。在任何患者中,细胞治疗均未引发恶性室性心律失常。对心肌梗死患者进行冠状动脉内输注骨髓单个核细胞并未改善心脏收缩功能,也未加重病情。